Comparing surgical techniques for pancreatic tumors
Evaluation of Resection Techniques for Pancreatic Tumors
Methodist Health System · NCT05128890
This study is testing whether open surgery or minimally invasive surgery works better for people with pancreatic and liver tumors by looking at their recovery and outcomes after the procedures.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 431 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Methodist Health System (other) |
| Locations | 1 site (Dallas, Texas) |
| Trial ID | NCT05128890 on ClinicalTrials.gov |
What this trial studies
This study evaluates the outcomes of open versus minimally invasive surgical techniques for pancreatic and liver tumor resections. It involves a retrospective chart review of patients who underwent these surgeries at Methodist Dallas Medical Center from January 2006 to December 2020. The study will analyze various outcome variables, including patient survival, length of hospital stay, complication rates, operative time, transfusion rates, and readmission rates at 30 and 90 days post-surgery.
Who should consider this trial
Good fit: Ideal candidates are patients aged 18 and older who have undergone pancreatic or liver resection surgeries at Methodist Dallas Medical Center during the specified time frame.
Not a fit: Patients who have not undergone pancreatic or liver resection surgeries or are under 18 years of age will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could help identify the most effective surgical techniques for improving patient outcomes in pancreatic and liver tumor resections.
How similar studies have performed: Other studies have shown varying success with similar surgical technique comparisons, but this specific evaluation is novel in its comprehensive approach to analyzing multiple outcome variables.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients that have undergone pancreatic or liver resection surgeries from January 2006 until December 2020 at Methodist Dallas Medical Center (MDMC) * Patients 18 years old or older Exclusion Criteria: * Patients that have not undergone pancreatic resection surgeries * Patients under 18 years of age
Where this trial is running
Dallas, Texas
- Methodist Dallas Medical Center — Dallas, Texas, United States (RECRUITING)
Study contacts
- Principal investigator: Alejandro Mejia, M.D. — The Liver Institute, Methodist Dallas Medical Center
- Study coordinator: Colette N Ndjom, MS
- Email: ClinicalResearch@mhd.com
- Phone: 214-947-4681
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Surgery, Liver Tumor, Pancreas Tumor